4th Annual CKD Drug Development Summit

1-3 March, 2022
Boston, USA

ENYO attended the 4th Chronic Kidney Disease Drug Development Summit, the only industry-led event dedicated to accelerating the frontier of preventative and regenerative therapies to meaningfully target kidney disease and enlighten opportunities for indication expansion into rare renal disorders. We presented a poster entitled “VONAFEXOR induces renal and hepatic improvements in NASH-LIVIFY trial results”.

Read more »

Tech Tour Growth & EIC ScalingUP 2022

28 Feb-4 March 2022
Digital event

Jacky Vonderscher presented ENYO Pharma and gave a pitch in the “Biotech, Pharma, Therapeutics” session in front of strategic investors & partners among the top 50 European deep tech growth companies funded by EIC.–eic-scalingup-2022%5B2%5D.html

Read more »

5th NASH Summit 2021

November 29 – December 2, 2021
100% digital

Dr Pietro Scalfaro, CMO of the company, will present latest Vonafexor data at the 5th NASH Summit. This conference aims at deepening understanding of early, translational and late stage clinical science to support NASH candidate entry to market.

Read more »

The Liver Meeting / AASLD 2021

12-15 November, 2021
Hybrid edition

ENYO Pharma will attend the 2021 edition of AASLD / The Liver meeting.

Read more »

International Workshop on HBV Cure 2021 (Sponsorship)

Virtual Event
9-10 November 2021

ENYO Pharma sponsors and attends the International Workshop on HBV Cure 2021 organized by Virology Education in close collaboration with the Toronto Centre for Liver Disease and chaired by Drs. Harry Janssen and Adam Gehring, the International Workshop on HBV Cure.

Read more »